Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on April 3, 2026
Apr. 3, 2026
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Indeterminate
GlobeNewswire
Apr. 3, 2026
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Integrity Health Introduces Career-Ready Patient Care Technician Courses
Indeterminate
EIN Presswire
Apr. 3, 2026
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
Indeterminate
GlobeNewswire
Apr. 3, 2026
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
Indeterminate
GlobeNewswire
Apr. 3, 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
Indeterminate
GlobeNewswire
Apr. 3, 2026
IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
Apr. 3, 2026
VitalRIZE Claims Evaluated: The Max Vitalize Virility Enhancement Support Supplement for Men
Indeterminate
GlobeNewswire
Apr. 3, 2026
Weight Watchers Announces Leadership Transition and Board Updates
Indeterminate
GlobeNewswire
Apr. 3, 2026
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire